Janssen to expand patent case against Juno over generic HIV drug
Angela McDonald 2020-07-01 4:40 pm By Miklos Bolza Sydney
Please login to bookmark Close

Drug manufacturer Janssen wants to expand its high stakes case against Juno Pharmaceuticals over its HIV drug Prezista, alleging Juno’s plans to launch a generic version of the drug threaten another one of its patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au